TMS Co., Ltd. (TYO:4891)
Japan · Delayed Price · Currency is JPY 125.00
0.00 (0.00%)
Sep 16, 2026, 3:30 PM JST
TMS Co., Ltd. Market Cap
TMS Co., Ltd. has a market cap or net worth of 5.71 billion as of September 15, 2026. Its market cap has decreased by -17.37% in one year.
Market Cap
5.71B
Enterprise Value
3.25B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
125.00
ChartMarket Cap Chart
Since November 22, 2022, TMS Co., Ltd.'s market cap has decreased from 28.10B to 5.71B, a decrease of -79.68%. That is a compound annual growth rate of -34.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 5.71B | -2.72% |
| Dec 30, 2025 | 5.87B | -33.26% |
| Dec 30, 2024 | 8.79B | 27.76% |
| Dec 29, 2023 | 6.88B | -69.65% |
| Dec 30, 2022 | 22.68B | -19.29% |
| Nov 22, 2022 | 28.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chiome Bioscience | 6.79B |
| MEDINET | 6.78B |
| CellSource | 6.31B |
| Cyfuse Biomedical K.K. | 6.05B |
| Noile-Immune Biotech | 6.03B |
| PRISM BioLab Co.,LTD | 5.99B |
| Soiken Holdings | 5.57B |
| Chordia Therapeutics | 5.33B |